|
1
|
Witjes JA, Compérat E, Cowan NC, De Santis
M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG and Sherif A;
European Association of Urology, : EAU guidelines on
muscle-invasive and metastatic bladder cancer: Summary of the 2013
guidelines. Eur Urol. 65:778–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeGeorge KC, Holt HR and Hodges SC:
Bladder cancer: Diagnosis and treatment. Am Fam Physician.
96:507–514. 2017.PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dinney CP, McConkey DJ, Millikan RE, Wu X,
Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi
AL, et al: Focus on bladder cancer. Cancer Cell. 6:111–116. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Wang Z, Yu J, Shi JZ, Wang C, Fu
WH, Chen ZW and Yang J: Cancer stem-like cells contribute to
cisplatin resistance and progression in bladder cancer. Cancer
Lett. 322:70–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Lin K, Yang Z, Han N, Quan X, Guo X
and Li C: Bladder cancer stem cells: Clonal origin and therapeutic
perspectives. Oncotarget. 8:66668–66679. 2017.PubMed/NCBI
|
|
7
|
Shiozawa Y, Nie B, Pienta KJ, Morgan TM
and Taichman RS: Cancer stem cells and their role in metastasis.
Pharmacol Ther. 138:285–293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shervington A and Lu C: Expression of
multidrug resistance genes in normal and cancer stem cells. Cancer
Invest. 26:535–542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hatina J, Parmar HS, Kripnerova M, Hepburn
A and Heer R: Urothelial carcinoma stem cells: Current concepts,
controversies, and methods. Methods Mol Biol. 1655:121–136. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chan KS, Espinosa I, Chao M, Wong D,
Ailles L, Diehn M, Gill H, Presti J Jr, Chang HY, van de Rijn M, et
al: Identification, molecular characterization, clinical prognosis,
and therapeutic targeting of human bladder tumor-initiating cells.
Proc Natl Acad Sci USA. 106:14016–14021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Syed IS, Pedram A and Farhat WA: Role of
sonic hedgehog (Shh) signaling in bladder cancer stemness and
tumorigenesis. Curr Urol Rep. 17:112016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qian W, Kong X, Zhang T, Wang D, Song J,
Li Y, Li X, Geng H, Min J, Kong Q, et al: Cigarette smoke
stimulates the stemness of renal cancer stem cells via sonic
hedgehog pathway. Oncogenesis. 7:242018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Islam SS, Mokhtari RB, Noman AS, Uddin M,
Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H and Farhat
WA: Sonic hedgehog (Shh) signaling promotes tumorigenicity and
stemness via activation of epithelial-to-mesenchymal transition
(EMT) in bladder cancer. Mol Carcinog. 55:537–551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fujiki H, Watanabe T, Sueoka E, Rawangkan
A and Suganuma M: Cancer prevention with green tea and its
principal constituent, EGCG: From early investigations to current
focus on human cancer stem cells. Mol Cells. 41:73–82.
2018.PubMed/NCBI
|
|
15
|
Luo KW, Chen W, Lung WY, Wei XY, Cheng BH,
Cai ZM and Huang WR: EGCG inhibited bladder cancer SW780 cell
proliferation and migration both in vitro and in vivo via
downregulation of NF-κB and MMP-9. J Nutr Biochem. 41:56–64. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo KW, Lung WY, Chun-Xie, Luo XL and
Huang WR: EGCG inhibited bladder cancer T24 and 5637 cell
proliferation and migration via PI3K/AKT pathway. Oncotarget.
9:12261–12272. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu J, Jiang Y, Yang X, Wang S, Xie C, Li
X, Li Y, Chen Y, Wang X, Meng Y, et al: Wnt/β-catenin pathway
mediates (−)-Epigallocatechin-3-gallate (EGCG) inhibition of lung
cancer stem cells. Biochem Biophys Res Commun. 482:15–21. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Wang XQ, Zhang Q, Zhu JY, Li Y,
Xie CF, Li XT, Wu JS, Geng SS, Zhong CY and Han HY:
(−)-Epigallocatechin-3-Gallate inhibits colorectal cancer stem
cells by suppressing Wnt/β-catenin pathway. Nutrients. 9:E5722017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin CH, Chao LK, Hung PH and Chen YJ: EGCG
inhibits the growth and tumorigenicity of nasopharyngeal
tumor-initiating cells through attenuation of STAT3 activation. Int
J Clin Exp Pathol. 7:2372–2381. 2014.PubMed/NCBI
|
|
20
|
Fujiki H, Sueoka E, Watanabe T and
Suganuma M: Synergistic enhancement of anticancer effects on
numerous human cancer cell lines treated with the combination of
EGCG, other green tea catechins, and anticancer compounds. J Cancer
Res Clin Oncol. 141:1511–1522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun FF, Hu YH, Xiong LP, Tu XY, Zhao JH,
Chen SS, Song J and Ye XQ: Enhanced expression of stem cell markers
and drug resistance in sphere-forming non-small cell lung cancer
cells. Int J Clin Exp Pathol. 8:6287–6300. 2015.PubMed/NCBI
|
|
23
|
Pozzi V, Sartini D, Rocchetti R,
Santarelli A, Rubini C, Morganti S, Giuliante R, Calabrese S, Di
Ruscio G, Orlando F, et al: Identification and characterization of
cancer stem cells from head and neck squamous cell carcinoma cell
lines. Cell Physiol Biochem. 36:784–798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williams SA, Anderson WC, Santaguida MT
and Dylla SJ: Patient-derived xenografts, the cancer stem cell
paradigm, and cancer pathobiology in the 21st century. Lab Invest.
93:970–982. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohishi T, Koga F and Migita T: Bladder
cancer stem-like cells: Their origin and therapeutic perspectives.
Int J Mol Sci. 17:E432015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sinha S and Chen JK: Purmorphamine
activates the hedgehog pathway by targeting Smoothened. Nat Chem
Biol. 2:29–30. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wubetu GY, Shimada M, Morine Y, Ikemoto T,
Ishikawa D, Iwahashi S, Yamada S, Saito Y, Arakawa Y and Imura S:
Epigallocatechin gallate hinders human hepatoma and colon cancer
sphere formation. J Gastroenterol Hepatol. 31:256–264. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang P, Xu C, Chen L, Chen A, Wu X, Zhou
M, Haq IU, Mariyam Z and Feng Q: Epigallocatechin-3-gallate
inhibited cancer stem cell-like properties by targeting
hsa-mir-485-5p/RXRα in lung cancer. J Cell Biochem. 119:8623–8635.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Toden S, Tran HM, Tovar-Camargo OA,
Okugawa Y and Goel A: Epigallocatechin-3-gallate targets cancer
stem-like cells and enhances 5-fluorouracil chemosensitivity in
colorectal cancer. Oncotarget. 7:16158–16171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fujiki H, Sueoka E, Rawangkan A and
Suganuma M: Human cancer stem cells are a target for cancer
prevention using (−)-epigallocatechin gallate. J Cancer Res Clin
Oncol. 143:2401–2412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mineva ND, Paulson KE, Naber SP, Yee AS
and Sonenshein GE: Epigallocatechin-3-gallate inhibits stem-like
inflammatory breast cancer cells. PLoS One. 8:e734642013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang D, Kong X, Li Y, Qian W, Ma J, Wang
D, Yu D and Zhong C: Curcumin inhibits bladder cancer stem cells by
suppressing sonic hedgehog pathway. Biochem Biophys Res Commun.
493:521–527. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang P, Watanabe M, Kaku H, Ueki H,
Noguchi H, Sugimoto M, Hirata T, Yamada H, Takei K, Zheng S, et al:
Cancer stem cell-like characteristics of a CD133+
subpopulation in the J82 human bladder cancer cell line. Mol Clin
Oncol. 1:180–184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Keymoosi H, Gheytanchi E, Asgari M,
Shariftabrizi A and Madjd Z: ALDH1 in combination with CD44 as
putative cancer stem cell markers are correlated with poor
prognosis in urothelial carcinoma of the urinary bladder. Asian Pac
J Cancer Prev. 15:2013–2020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sedaghat S, Gheytanchi E, Asgari M, Roudi
R, Keymoosi H and Madjd Z: Expression of cancer stem cell markers
OCT4 and CD133 in transitional cell carcinomas. Appl
Immunohistochem Mol Morphol. 25:196–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Amini S, Fathi F, Mobalegi J,
Sofimajidpour H and Ghadimi T: The expressions of stem cell
markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3,
Dppa4, and Esrrb in bladder, colon, and prostate cancer, and
certain cancer cell lines. Anat Cell Biol. 47:1–11. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Morata-Tarifa C, Jiménez G, García MA,
Entrena JM, Griñán-Lisón C, Aguilera M, Picon-Ruiz M and Marchal
JA: Low adherent cancer cell subpopulations are enriched in
tumorigenic and metastatic epithelial-to-mesenchymal
transition-induced cancer stem-like cells. Sci Rep. 6:187722016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu J, Yang X, Chen Y, Jiang Y, Wang SJ,
Li Y, Wang XQ, Meng Y, Zhu MM, Ma X, et al: Curcumin suppresses
lung cancer stem cells via inhibiting Wnt/β-catenin and sonic
hedgehog pathways. Phytother Res. 31:680–688. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li X, Meng Y, Xie C, Zhu J, Wang X, Li Y,
Geng S, Wu J, Zhong C and Li M: Diallyl Trisulfide inhibits breast
cancer stem cells via suppression of Wnt/β-catenin pathway. J Cell
Biochem. 119:4134–4141. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang F, Wang W, Li J, Zhang J, Wang X and
Wang M: Sulforaphane reverses gefitinib tolerance in human lung
cancer cells via modulation of sonic hedgehog signaling. Oncol
Lett. 15:109–114. 2018.PubMed/NCBI
|
|
42
|
Li X, Wang X, Xie C, Zhu J, Meng Y, Chen
Y, Li Y, Jiang Y, Yang X, Wang S, et al: Sonic hedgehog and
Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer
stem cells. Anticancer Drugs. 29:208–215. 2018.PubMed/NCBI
|
|
43
|
Tessmann JW, Buss J, Begnini KR, Berneira
LM, Paula FR, de Pereira CM, Collares T and Seixas FK: Antitumor
potential of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles in
human bladder cancer cells. Biomed Pharmacother. 94:37–46. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu Q, Yuan W, Tong D, Liu G, Lan W, Zhang
D, Xiao H, Zhang Y, Huang Z, Yang J, et al: Metformin represses
bladder cancer progression by inhibiting stem cell repopulation via
COX2/PGE2/STAT3 axis. Oncotarget. 7:28235–28246. 2016.PubMed/NCBI
|
|
45
|
Dutta S, Mahalanobish S, Saha S, Ghosh S
and Sil PC: Natural products: An upcoming therapeutic approach to
cancer. Food Chem Toxicol. 128:240–255. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Villavicencio EH, Walterhouse DO and
Iannaccone PM: The sonic hedgehog-patched-gli pathway in human
development and disease. Am J Hum Genet. 67:1047–1054. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
DeSouza KR, Saha M, Carpenter AR, Scott M
and McHugh KM: Analysis of the sonic hedgehog signaling pathway in
normal and abnormal bladder development. PLoS One. 8:e536752013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu S, Dontu G, Mantle ID, Patel S, Ahn
NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1
regulate self-renewal of normal and malignant human mammary stem
cells. Cancer Res. 66:6063–6071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wu X, Walker J, Zhang J, Ding S and
Schultz PG: Purmorphamine induces osteogenesis by activation of the
hedgehog signaling pathway. Chem Biol. 11:1229–1238. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Oliveira FS, Bellesini LS, Defino HL, da
Silva Herrero CF, Beloti MM and Rosa AL: Hedgehog signaling and
osteoblast gene expression are regulated by purmorphamine in human
mesenchymal stem cells. J Cell Biochem. 113:204–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xu M, Gong A, Yang H, George SK, Jiao Z,
Huang H, Jiang X and Zhang Y: Sonic hedgehog-glioma associated
oncogene homolog 1 signaling enhances drug resistance in
CD44(+)/Musashi-1(+) gastric cancer stem cells. Cancer Lett.
369:124–133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang L, Li L, Jiao M, Wu D, Wu K, Li X,
Zhu G, Yang L, Wang X, Hsieh JT and He D: Genistein inhibits the
stemness properties of prostate cancer cells through targeting
hedgehog-Gli1 pathway. Cancer Lett. 323:48–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ma D, Yu H, Xu S, Wang H, Zhang X, Ning T
and Wu B: Stathmin inhibits proliferation and differentiation of
dental pulp stem cells via sonic hedgehog/Gli. J Cell Mol Med.
22:3442–3451. 2018. View Article : Google Scholar : PubMed/NCBI
|
